E. Maartense - Concepedia

Author

E. Maartense

Reinier de Graaf Hospital

Also Known As

E Maartense, E. Maartense, Eduard Maartense

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Reinier de Graaf Hospital Leiden University Medical Center Diakonessenhuis hospital The Netherlands Cancer Institute Netherlands Comprehensive Cancer Organisation

About

E. Maartense is an author at Reinier de Graaf Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	689
2	Epidemiology	2	2	84
3	Health Sciences	1	1	20
4	Nursing	1	1	133
5	Public Health	1	1	27

E. Maartense

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study Gϋnter von Minckwitz, Andreas du Bois, Marcus Schmidt, Journal of Clinical Oncology	2009	687
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to <i>BRAF</i> Mutation and Mismatch Repair Status of the MOSAIC Study Thierry André, Armand de Gramont, Déwi Vernerey, Journal of Clinical Oncology	2015	658
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma M Krámer, Jos Hermans, E.R. Wijburg, Blood	1998	488
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) Erik J. Blok, Judith R. Kroep, Elma Meershoek‐Klein Kranenbarg, JNCI Journal of the National Cancer Institute	2017	196
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer Gϋnter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, European Journal of Cancer Breast OncologyMedicinePathologyBreast CancerGbg 26/Big	2011	183
Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group Marije E. Hamaker, Caroline Seynaeve, A.N.M. Wymenga, The Breast NursingGeriatric OncologyOncologyAgingBreast Oncology	2013	133
Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? S.J.T. Jansen, J. Kievit, M. Nooij, British Journal of Cancer	2001	99
Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy Ab A. Aaldriks, Erik J. Giltay, Saskia le Cessie, The Breast	2013	74
A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok, Annals of Oncology Breast OncologyOncologyElderly PatientsOmega StudyMedicine	2014	60
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma M Krámer, Jos Hermans, E.R. Wijburg, Blood	1998	59

Page 1